{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:12:15Z","timestamp":1792735935123,"version":"4.5.0"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T00:00:00Z","timestamp":1354147200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0001920","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T22:40:35Z","timestamp":1354228835000},"page":"e1920","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":49,"title":["In-Hospital Safety in Field Conditions of Nifurtimox Eflornithine Combination Therapy (NECT) for T. b. gambiense Sleeping Sickness"],"prefix":"10.1371","volume":"6","author":[{"given":"Caecilia","family":"Schmid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kuemmerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah","family":"Ghabri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Kande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Mutombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medard","family":"Ilunga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael","family":"Lumpungu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Mutanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pathou","family":"Nganzobo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Digas","family":"Tete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nono","family":"Mubwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mays","family":"Kisala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severine","family":"Blesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf Valverde","family":"Mordt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,11,29]]},"reference":[{"key":"ref1","unstructured":"WHO (2011) Neglected Tropical Diseases. Available: http:\/\/www.who.int\/trypanosomiasis_african\/en\/<\/ext-link>. Accessed 2012 Feb 20."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1476-072X-9-57","article-title":"The Atlas of human African trypanosomiasis: a contribution to global mapping of neglected tropical diseases","volume":"9","author":"PP Simarro","year":"2010","journal-title":"Int J Health Geogr"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1086\/429929","article-title":"Effectiveness of a 10-day melarsoprol schedule for the treatment of late-stage human African trypanosomiasis: Confirmation from a multinational study (Impamel II)","volume":"191","author":"C Schmid","year":"2005","journal-title":"Journal of Infectious Diseases"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.trstmh.2008.09.005","article-title":"Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Medecins Sans Frontieres programmes","volume":"103","author":"M Balasegaram","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref5","unstructured":"Dahl B (2011) From sentinel surveillance for sleeping sickness treatment failure to the development of a pharmacovigilance approach [PhD thesis]. Basel: University of Basel. 149 p."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3201\/eid1406.071266","article-title":"High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo","volume":"14","author":"J Robays","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"921","DOI":"10.3201\/eid1106.050036","article-title":"Trypanosomiasis relapse after melarsoprol therapy, Democratic Republic of Congo, 1982\u20132001","volume":"11","author":"J Pepin","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1046\/j.1365-3156.2001.00712.x","article-title":"Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda","volume":"6","author":"E Matovu","year":"2001","journal-title":"Trop Med Int Health"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1046\/j.1365-3156.2001.00724.x","article-title":"The situation of sleeping sickness in Angola: a calamity","volume":"6","author":"A Stanghellini","year":"2001","journal-title":"Tropical Medicine and International Health"},{"key":"ref10","unstructured":"WHO (2010) WHO Model List of Essential Medicines Available: http:\/\/www.who.int\/medicines\/publications\/essentialmedicines\/Updated_sixteenth_adult_list_en.pdf<\/ext-link>. Accessed 2012 Feb 20."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial","volume":"374","author":"G Priotto","year":"2009","journal-title":"Lancet"},{"key":"ref12","unstructured":"Program CTE (2006) Common Terminology Criteria for Adverse Events, Version 3.0 Available: http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/docs\/ctcaev3.pdf<\/ext-link>. Accessed 2012 Feb 20."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1086\/432576","article-title":"Eflornithine is safer than melarsoprol for the treatment of second-stage Trypanosoma brucei gambiense human African trypanosomiasis","volume":"41","author":"F Chappuis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/bmj.39485.592674.BE","article-title":"Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study","volume":"336","author":"G Priotto","year":"2008","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Fleiss JL, Levin B, Paik MC (2003) Statistical Methods for Rates and Proportions. New York: John Wiley & Sons.","DOI":"10.1002\/0471445428"},{"key":"ref16","unstructured":"NCSS (2008) PASS 2008 (http:\/\/www.ncss.com\/download_PASS11.html<\/ext-link>) accessed (20.02.2012)."},{"key":"ref17","unstructured":"MEDRA (2010) Medical Dictionary for regulatory activities - Maintenance and Service Support Organisation. Available: http:\/\/www.meddramsso.com\/index.asp<\/ext-link>. Accessed 2012 Feb 20."},{"key":"ref18","unstructured":"WHO (2006) ATC\/DDD Index (http:\/\/www.whocc.no\/atc_ddd_index\/<\/ext-link>) accessed (20.02.2012)"},{"key":"ref19","unstructured":"WHO (1995) Physical status: The use and interpretation of anthropometry (http:\/\/whqlibdoc.who.int\/trs\/WHO_TRS_854.pdf<\/ext-link>) Accessed 2012 Feb 20."},{"key":"ref20","unstructured":"WHO (2007) Growth reference data for 5\u201319 years. Available: http:\/\/www.who.int\/growthref\/en\/<\/ext-link>. Accessed 2012 Feb 20."},{"key":"ref21","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1371\/journal.pctr.0010039","article-title":"Three drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Uganda","volume":"1","author":"G Priotto","year":"2006","journal-title":"PLoS Clin Trials"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1371\/journal.pntd.0000064","article-title":"Nifurtimox plus Eflornithine for Late-Stage Sleeping Sickness in Uganda: A Case Series","volume":"1","author":"F Checchi","year":"2007","journal-title":"PLoS Negl Trop Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.actatropica.2005.08.001","article-title":"Clinical aspects of 2541 patients with second stage human African trypanosomiasis","volume":"97","author":"J Blum","year":"2006","journal-title":"Acta Trop"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1371\/journal.pntd.0000383","article-title":"Cardiac Alterations in Human African Trypanosomiasis (T.b. gambiense) with Respect to the Disease Stage and Antiparasitic Treatment","volume":"3","author":"JA Blum","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1046\/j.1365-3156.2001.00710.x","article-title":"Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis","volume":"6","author":"J Blum","year":"2001","journal-title":"Trop Med Int Health"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0140-6736(00)02141-3","article-title":"Efficacy of new, concise schedule for melarsoprol in treatment of sleeping sickness caused by Trypanosoma brucei gambiense: a randomised trial","volume":"355","author":"C Burri","year":"2000","journal-title":"Lancet"},{"key":"ref27","unstructured":"Seixas J (2005) Investigations on the encephalopathic syndrome during melarsoprol treatment of human african trypanosomiasis [PhD]. Lisboa: Universidade Nova de Lisboa. 250 p."}],"container-title":["PLoS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0001920","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T00:50:20Z","timestamp":1540255820000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0001920"}},"subtitle":[],"editor":[{"given":"Joseph Mathu","family":"Ndung'u","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,11,29]]},"references-count":27,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2012,11,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0001920","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,29]]}}}